Clearview Cancer Institute’s Bobbi Wilson knew she needed to get serious about routine cancer screening when her best friend was diagnosed with Stage IV Colon Cancer. She was younger than the average Colon Cancer patient, so it came as a shock to all.
When Bobbi turned 45, she spoke with her doctor about colorectal cancer screening options and he recommended Cologuard, an at-home, noninvasive test. Knowing she could complete the test from the comfort of her home and she didn’t need to take off of work, Bobbi went home and immediately ordered a kit.
What is Cologuard?
Cologuard is a test kit delivered directly to your doorstep. It contains everything needed to collect a stool sample in the comfort of your home. Once collected, the sample is sent to a certified laboratory for analysis. Using advanced DNA technology, Cologuard detects specific genetic markers and blood proteins associated with colon cancer and precancerous lesions.
Colorectal Cancer Awareness Month
March is Colorectal Cancer Awareness Month. Colorectal cancer, also known as colon cancer or rectal cancer, is a type of cancer that affects the colon and rectum, which are part of the large intestine. It is the third most common cancer and the second leading cause of cancer deaths in both men and women in the United States.
Prevention is key, so while colorectal cancer is most common in people over the age of 50, regular screening is recommended starting at age 45. Screening options include colonoscopies and stool tests such as Cologuard. We recommend speaking with your care team to determine which option is best for you.
Screenings can decrease mortality by detecing colorectal cancer at an early state and may decrease incidence of colorectal cancer by removing pre-cancerous polyps, or small cell growth in the lining of the colon. Don’t wait, schedule your screening today. It could save your life.